Clinical Trials Browser

Phase 1/2 × lutetium Lu 177 dotatate × CNS × Clear all

Diffuse Intrinsic Pontine Glioma, Ependymoma, Glioma, Medulloblastoma, Meningioma, Neoplasms, Germ Cell and Embryonal, Central Nervous System Neoplasms

NCT03923257 2021-06-08

Dosimetry Guided PRRT With 177Lu-DOTATATE in Children and Adolescents

Phase 1/2 Withdrawn

CNSEndocrineNET

Paraganglioma, Pheochromocytoma, Neuroendocrine Tumors

Clinical Trials

Lutathera for Treatment of Recurrent or Progressive High-Grade CNS Tumors

Dosimetry Guided PRRT With 177Lu-DOTATATE in Children and Adolescents